As shown in these sections concerning psychiatric disorders, boosting BDNF function through its specific receptor TrkB is indeed effective in improving symptoms of depression and schizophrenia, as judged by the results from using in vivo and in vitro models (see Figure 2). Here, BDNF is linked to depressive symptom measurement.